Recursion Pharmaceuticals, Inc. (RXRX)
3.11
+0.15
(+5.07%)
USD |
NASDAQ |
May 21, 16:00
3.11
0.00 (0.00%)
After-Hours: 19:59
Recursion Pharmaceuticals EPS Diluted (Quarterly) : -0.222 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8121 |
| Tango Therapeutics, Inc. | -0.317 |
| KalVista Pharmaceuticals, Inc. | -0.4303 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| Ironwood Pharmaceuticals, Inc. | 0.2446 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -117.50M |
| Revenue (Quarterly) | 6.472M |
| Total Expenses (Quarterly) | 123.98M |
| Enterprise Value | 1.063B |
| Gross Profit Margin (Quarterly) | -289.2% |
| Profit Margin (Quarterly) | -1.82K% |
| Earnings Yield | -38.66% |
| Normalized Earnings Yield | -38.65 |